PreScreening Data and Other Characteristics of Partners HSV-2 Study Sites

*2004 or 2005 census data. **From PEPFAR (http//www.pepfar.gov/): “National HIV-1 prevalence among adults aged 15–49” for each country listed. ˆClinical trial recruitment also extended to outlying districts with total population of 0.75–1.5 million persons. #Source of HIV-1 prevalence data: Kenya-reference [23]; Uganda–reference [7]; Tanzania–reference [24]; S. Africa–reference [25]; Zambia–reference [26]; Botswana–reference [27]. &-Total number of couples receiving HIV counseling and testing during previously defined recruitment periods: July 2005–April 2006 (Ndola and Kitwe, Zambia) and December 2006–April 2007 (all other Partners HSV-2 Study sites). @-NHRI calculated from PEPFAR data (http//www.pepfar.gov/) as: (“# individuals receiving counseling and testing in settings other than PMTCT in FY2006”+“# HIV-1 infected individuals receiving palliative care/basic health care and support in FY2006 (including HIV-1/TB)”)/“Adults and children (age 0–49) living with HIV-1 at the end of 2005”.